News

Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024?

Wise investors are placing some biotech stocks on their watchlists this month, as these companies have surged over 160%. With more predicted upside to these companies than we see today, one could book some serious capital appreciation into a portfolio.

04/15/2024

Rezolute: Negative EV Opportunity Initiating A Phase 3 Ultra-Orphan Pediatric Study

Rezolute is a clinical-stage biotechnology company focused on metabolic diseases related to glucose control. Their lead asset, RZ358, is a monoclonal antibody being developed as a treatment for hyperinsulinism, a condition characterized by excessive insulin production. The Company is trading for 50% of cash, about to initiate a phase 3 study in an ultra-orphan indication, with significant potential upside on a valuation basis.

11/09/2023

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Rezolute, Inc. (RZLT) a buy, sell, or hold?

Rezolute, Inc. (RZLT) can sell. Click on Rating Page for detail.

What is Rezolute, Inc.'s stock price?

The price of Rezolute, Inc. (RZLT) is 3.31 and it was updated on 2024-05-05 07:00:43.

Is Rezolute, Inc. (RZLT) overvalued or undervalued?

Currently Rezolute, Inc. (RZLT) is in undervalued.

News

From:

To:

News
Rezolute to Participate in Upcoming Investor Conferences in September REDWOOD CITY, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company dedicated to developing transformative therapies with the potential to disrupt current treatment paradigms for devastating metabolic diseases, today announced that Nevan Charles Elam, Chief Executive Officer and Founder, will participate in two upcoming investor conferences. Wed, Sep. 06, 2023
Rezolute to Present at the Jefferies London Healthcare Conference REDWOOD CITY, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company dedicated to developing transformative therapies with the potential to shift the treatment paradigms of devastating metabolic diseases, today announced that Nevan Charles Elam, Chief Executive Officer and Founder, will participate in a fireside chat at the Jefferies London Healthcare Conference on Thursday, November 17, 2022, at 11:25 a.m. EST/4:25 p.m. GMT. Tue, Nov. 01, 2022
Rezolute, Inc. (RZLT) Upgraded to Buy: Here's Why Rezolute, Inc. (RZLT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Wed, Sep. 21, 2022
Rezolute (RZLT) Posts Positive Data From Congenital HI Study Rezolute (RZLT) releases favorable data from the phase IIb RIZE study on its lead candidate RZ358, currently being investigated for congenital hyperinsulinism. Thu, Mar. 24, 2022
Rezolute Announces Pricing of Public Offering of $55 million of Common Stock and Pre-Funded Warrants, and Concurrent Registered Direct Offering REDWOOD CITY, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases associated with chronic glucose imbalance, today announced the pricing of an underwritten public offering of 6,030,847 shares of its common stock at a public offering price of $6.50 per share and of pre-funded warrants to purchase 1,661,461 shares of its common stock at a public offering price of $6.49 per pre-funded warrant, which represents the per share public offering price for the common stock less the $0.01 per share exercise price for each pre-funded warrant. Wed, Oct. 13, 2021

SEC Filings

SEC Filings
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 04/25/2024
Rezolute, Inc. (RZLT) - DEF 14A SEC Filings 04/15/2024
Rezolute, Inc. (RZLT) - 4 SEC Filings 03/29/2024
Rezolute, Inc. (RZLT) - 4 SEC Filings 03/19/2024
Rezolute, Inc. (RZLT) - 4/A SEC Filings 03/18/2024
Rezolute, Inc. (RZLT) - 4 SEC Filings 03/18/2024
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 03/14/2024
Rezolute, Inc. (RZLT) - 4 SEC Filings 03/14/2024
Rezolute, Inc. (RZLT) - SC 13G SEC Filings 03/11/2024
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 03/11/2024
Rezolute, Inc. (RZLT) - 4 SEC Filings 03/11/2024
Rezolute, Inc. (RZLT) - 4 SEC Filings 03/08/2024
Rezolute, Inc. (RZLT) - 4 SEC Filings 02/28/2024
Rezolute, Inc. (RZLT) - 4 SEC Filings 02/27/2024
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 02/22/2024
Rezolute, Inc. (RZLT) - 4 SEC Filings 02/21/2024
Rezolute, Inc. (RZLT) - 4 SEC Filings 02/20/2024
Rezolute, Inc. (RZLT) - SC 13G/A SEC Filings 02/13/2024
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 02/13/2024
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 02/13/2024
Rezolute, Inc. (RZLT) - SC 13G/A SEC Filings 02/12/2024
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 01/29/2024
Rezolute, Inc. (RZLT) - 4 SEC Filings 01/25/2024
Rezolute, Inc. (RZLT) - 3 SEC Filings 01/25/2024
Rezolute, Inc. (RZLT) - SC 13G/A SEC Filings 01/18/2024
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 12/14/2023
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 11/30/2023
Rezolute, Inc. (RZLT) - S-3/A SEC Filings 11/22/2023
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 11/22/2023
Rezolute, Inc. (RZLT) - S-3 SEC Filings 11/14/2023
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 11/13/2023
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 11/13/2023
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 10/18/2023
Rezolute, Inc. (RZLT) - SC 13G SEC Filings 10/13/2023
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 10/13/2023
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 09/14/2023
Rezolute, Inc. (RZLT) - 10-K - Current report SEC Filings 09/14/2023
Rezolute, Inc. (RZLT) - 4 SEC Filings 07/06/2023
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 06/27/2023
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 06/20/2023
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 06/02/2023
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 05/26/2023
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 05/11/2023
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 05/11/2023
Rezolute, Inc. (RZLT) - SC 13D/A SEC Filings 05/03/2023
Rezolute, Inc. (RZLT) - DEFA14A SEC Filings 04/12/2023
Rezolute, Inc. (RZLT) - DEF 14A SEC Filings 04/12/2023
Rezolute, Inc. (RZLT) - SC 13G/A SEC Filings 02/14/2023
Rezolute, Inc. (RZLT) - SC 13G SEC Filings 02/14/2023
Rezolute, Inc. (RZLT) - SC 13G/A SEC Filings 02/13/2023
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 02/10/2023
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 02/10/2023
Rezolute, Inc. (RZLT) - SC 13G/A SEC Filings 02/01/2023
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 01/13/2023
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 12/15/2022
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 11/10/2022
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 11/09/2022
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 11/09/2022
Rezolute, Inc. (RZLT) - S-8 SEC Filings 11/07/2022
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 11/07/2022
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 11/04/2022
Rezolute, Inc. (RZLT) - S-3 SEC Filings 10/28/2022
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 09/15/2022
Rezolute, Inc. (RZLT) - 10-K - Current report SEC Filings 09/15/2022
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 07/05/2022
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 07/05/2022
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 07/01/2022
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 07/01/2022
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 06/29/2022
Rezolute, Inc. (RZLT) - S-3/A SEC Filings 06/28/2022
Rezolute, Inc. (RZLT) - 4 SEC Filings 06/28/2022
Rezolute, Inc. (RZLT) - SC 13G SEC Filings 06/27/2022
Rezolute, Inc. (RZLT) - 4 SEC Filings 06/27/2022
Rezolute, Inc. (RZLT) - S-3 SEC Filings 06/17/2022
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 06/17/2022
Rezolute, Inc. (RZLT) - 424B5 SEC Filings 05/20/2022
Rezolute, Inc. (RZLT) - 4 SEC Filings 05/19/2022
Rezolute, Inc. (RZLT) - DEF 14A SEC Filings 05/16/2022
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 05/16/2022
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 05/12/2022
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 05/12/2022
Rezolute, Inc. (RZLT) - 4/A SEC Filings 05/09/2022
Rezolute, Inc. (RZLT) - PRE 14A SEC Filings 05/06/2022
Rezolute, Inc. (RZLT) - 4 SEC Filings 05/06/2022
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 05/04/2022
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 05/02/2022
Rezolute, Inc. (RZLT) - 424B5 SEC Filings 05/02/2022
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 03/30/2022
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 03/23/2022
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 02/22/2022
Rezolute, Inc. (RZLT) - SC 13G/A SEC Filings 02/14/2022
Rezolute, Inc. (RZLT) - SC 13G/A SEC Filings 02/11/2022
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 02/09/2022
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 02/09/2022
Rezolute, Inc. (RZLT) - SC 13G SEC Filings 12/27/2021
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 11/12/2021
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 11/12/2021
Rezolute, Inc. (RZLT) - SC 13G/A SEC Filings 11/10/2021
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 10/19/2021
Rezolute, Inc. (RZLT) - 424B5 SEC Filings 10/14/2021
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 10/13/2021
Rezolute, Inc. (RZLT) - 424B5 SEC Filings 10/12/2021
Rezolute, Inc. (RZLT) - 10-K/A - Current report SEC Filings 09/27/2021
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 09/23/2021
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 09/15/2021
Rezolute, Inc. (RZLT) - 10-K - Current report SEC Filings 09/15/2021
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 09/13/2021
Rezolute, Inc. (RZLT) - 4/A SEC Filings 08/31/2021
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 08/11/2021
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 08/04/2021
Rezolute, Inc. (RZLT) - 424B5 SEC Filings 08/04/2021
Rezolute, Inc. (RZLT) - SC 13D SEC Filings 07/28/2021
Rezolute, Inc. (RZLT) - S-8 SEC Filings 07/28/2021
Rezolute, Inc. (RZLT) - 4 SEC Filings 07/28/2021
Rezolute, Inc. (RZLT) - 3 SEC Filings 07/28/2021
Rezolute, Inc. (RZLT) - 4 SEC Filings 07/14/2021
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 06/28/2021
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 06/25/2021
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 06/24/2021
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 06/24/2021
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 06/24/2021
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 06/24/2021
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 06/24/2021
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 06/24/2021
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 06/24/2021
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 06/24/2021
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 06/24/2021
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 06/23/2021
Rezolute, Inc. (RZLT) - POS AM SEC Filings 06/21/2021
Rezolute, Inc. (RZLT) - 8-K12B - Current report SEC Filings 06/21/2021
Rezolute, Inc. (RZLT) - 8-A12B/A SEC Filings 06/21/2021
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 06/02/2021
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 05/17/2021
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 05/17/2021
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 05/04/2021
Rezolute, Inc. (RZLT) - DEF 14A SEC Filings 04/28/2021
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 04/19/2021
Rezolute, Inc. (RZLT) - PRE 14A SEC Filings 04/12/2021
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 03/08/2021
Rezolute, Inc. (RZLT) - 3 SEC Filings 03/08/2021
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 02/18/2021
Rezolute, Inc. (RZLT) - SC 13G/A SEC Filings 02/12/2021
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 02/10/2021
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 02/10/2021
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 01/07/2021
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 01/06/2021
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 12/29/2020
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 12/28/2020
Rezolute, Inc. (RZLT) - S-3/A SEC Filings 12/22/2020
Rezolute, Inc. (RZLT) - S-3 SEC Filings 12/18/2020
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 12/03/2020
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 11/30/2020
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 11/27/2020
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 11/23/2020
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 11/19/2020
Rezolute, Inc. (RZLT) - S-3 SEC Filings 11/13/2020
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 11/12/2020
Rezolute, Inc. (RZLT) - SC 13G SEC Filings 11/10/2020
Rezolute, Inc. (RZLT) - CERT SEC Filings 11/09/2020
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 11/06/2020
Rezolute, Inc. (RZLT) - 3/A SEC Filings 11/05/2020
Rezolute, Inc. (RZLT) - 8-A12B SEC Filings 11/04/2020
Rezolute, Inc. (RZLT) - 3 SEC Filings 10/30/2020
Rezolute, Inc. (RZLT) - D SEC Filings 10/22/2020
Rezolute, Inc. (RZLT) - SC 13G SEC Filings 10/14/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 10/14/2020
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 10/13/2020
Rezolute, Inc. (RZLT) - 10-K - Current report SEC Filings 10/13/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 10/08/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 10/07/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 10/05/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 10/02/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 09/30/2020
Rezolute, Inc. (RZLT) - NT 10-K - Current report SEC Filings 09/29/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 09/28/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 09/25/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 09/23/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 09/21/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 09/18/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 09/16/2020
Rezolute, Inc. (RZLT) - 3 SEC Filings 09/16/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 09/15/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 09/14/2020
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 09/10/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 09/10/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 09/08/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 09/04/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 09/02/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 09/01/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 08/28/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 08/26/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 08/25/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 08/21/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 08/19/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 08/18/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 08/14/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 08/12/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 08/11/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 08/07/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 08/05/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 08/04/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 08/03/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 07/30/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 07/28/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 07/24/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 07/22/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 07/21/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 07/17/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 07/16/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 07/15/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 07/14/2020
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 05/14/2020
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 04/02/2020
Rezolute, Inc. (RZLT) - SC 13D SEC Filings 03/31/2020
Rezolute, Inc. (RZLT) - 4 SEC Filings 03/31/2020
Rezolute, Inc. (RZLT) - 3 SEC Filings 03/31/2020
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 02/12/2020
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 12/09/2019
Rezolute, Inc. (RZLT) - 3 SEC Filings 12/09/2019
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 12/06/2019
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 12/06/2019
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 12/04/2019
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 12/04/2019
Rezolute, Inc. (RZLT) - 3 SEC Filings 11/27/2019
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 11/25/2019
Rezolute, Inc. (RZLT) - S-1 SEC Filings 11/18/2019
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 11/14/2019
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 10/29/2019
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 10/23/2019
Rezolute, Inc. (RZLT) - DEF 14A SEC Filings 09/23/2019
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 09/19/2019
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 09/19/2019
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 09/19/2019
Rezolute, Inc. (RZLT) - PRER14A SEC Filings 09/16/2019
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 09/16/2019
Rezolute, Inc. (RZLT) - 4 SEC Filings 09/16/2019
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 09/12/2019
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 09/12/2019
Rezolute, Inc. (RZLT) - S-1/A SEC Filings 09/10/2019
Rezolute, Inc. (RZLT) - 10-K - Current report SEC Filings 09/10/2019
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 09/09/2019
Rezolute, Inc. (RZLT) - PRE 14A SEC Filings 09/06/2019
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 08/28/2019
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 08/26/2019
Rezolute, Inc. (RZLT) - S-1/A SEC Filings 08/19/2019
Rezolute, Inc. (RZLT) - S-1 SEC Filings 08/15/2019
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 08/13/2019
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 08/06/2019
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 07/30/2019
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 06/17/2019
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 05/20/2019
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 05/10/2019
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 04/30/2019
Rezolute, Inc. (RZLT) - DEF 14A SEC Filings 04/05/2019
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 04/04/2019
Rezolute, Inc. (RZLT) - PRER14A SEC Filings 03/28/2019
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 03/28/2019
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 03/25/2019
Rezolute, Inc. (RZLT) - CT ORDER SEC Filings 03/18/2019
Rezolute, Inc. (RZLT) - PRE 14A SEC Filings 03/11/2019
Rezolute, Inc. (RZLT) - 3 SEC Filings 03/11/2019
Rezolute, Inc. (RZLT) - 3 SEC Filings 03/08/2019
Rezolute, Inc. (RZLT) - 3 SEC Filings 03/07/2019
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 02/14/2019
Rezolute, Inc. (RZLT) - SC 14F1 SEC Filings 01/31/2019
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 01/31/2019
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 01/11/2019
Rezolute, Inc. (RZLT) - 10-K/A - Current report SEC Filings 12/31/2018
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 12/14/2018
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 11/27/2018
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 10/16/2018
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 10/15/2018
Rezolute, Inc. (RZLT) - 10-K - Current report SEC Filings 10/15/2018
Rezolute, Inc. (RZLT) - NT 10-K - Current report SEC Filings 10/01/2018
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 08/01/2018
Rezolute, Inc. (RZLT) - CT ORDER SEC Filings 06/25/2018
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 06/19/2018
Rezolute, Inc. (RZLT) - 3 SEC Filings 05/17/2018
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 05/16/2018
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 05/15/2018
Rezolute, Inc. (RZLT) - SC 13G SEC Filings 04/30/2018
Rezolute, Inc. (RZLT) - 3 SEC Filings 04/30/2018
Rezolute, Inc. (RZLT) - D/A SEC Filings 04/24/2018
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 04/09/2018
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 04/04/2018
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 04/03/2018
Rezolute, Inc. (RZLT) - SC 13D SEC Filings 03/28/2018
Rezolute, Inc. (RZLT) - CT ORDER SEC Filings 03/15/2018
Rezolute, Inc. (RZLT) - D SEC Filings 02/15/2018
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 02/15/2018
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 02/14/2018
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 02/14/2018
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 02/09/2018
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 02/09/2018
Rezolute, Inc. (RZLT) - D/A SEC Filings 02/07/2018
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 02/05/2018
Rezolute, Inc. (RZLT) - S-1 SEC Filings 01/29/2018
Rezolute, Inc. (RZLT) - D SEC Filings 01/11/2018
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 12/26/2017
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 12/19/2017
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 12/07/2017
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 12/06/2017
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 11/29/2017
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 11/14/2017
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 11/09/2017
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 11/09/2017
Rezolute, Inc. (RZLT) - S-1/A SEC Filings 11/07/2017
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 11/07/2017
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 11/06/2017
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 11/03/2017
Rezolute, Inc. (RZLT) - S-1/A SEC Filings 10/31/2017
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 10/31/2017
Rezolute, Inc. (RZLT) - DEF 14A SEC Filings 10/20/2017
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 10/17/2017
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 10/13/2017
Rezolute, Inc. (RZLT) - PRER14A SEC Filings 10/13/2017
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 10/13/2017
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 10/11/2017
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 10/10/2017
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 10/05/2017
Rezolute, Inc. (RZLT) - PRE 14A SEC Filings 09/27/2017
Rezolute, Inc. (RZLT) - S-1 SEC Filings 09/22/2017
Rezolute, Inc. (RZLT) - 10-K - Current report SEC Filings 09/22/2017
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 08/07/2017
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 07/25/2017
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 07/17/2017
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 06/05/2017
Rezolute, Inc. (RZLT) - D SEC Filings 05/31/2017
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 05/15/2017
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 05/09/2017
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 05/01/2017
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 03/22/2017
Rezolute, Inc. (RZLT) - 4 SEC Filings 03/15/2017
Rezolute, Inc. (RZLT) - 4 SEC Filings 03/08/2017
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 03/06/2017
Rezolute, Inc. (RZLT) - 4 SEC Filings 02/17/2017
Rezolute, Inc. (RZLT) - D SEC Filings 02/14/2017
Rezolute, Inc. (RZLT) - 4 SEC Filings 02/13/2017
Rezolute, Inc. (RZLT) - 4 SEC Filings 02/09/2017
Rezolute, Inc. (RZLT) - SC TO-I/A SEC Filings 02/03/2017
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 02/02/2017
Rezolute, Inc. (RZLT) - 4 SEC Filings 01/24/2017
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 01/20/2017
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 01/20/2017
Rezolute, Inc. (RZLT) - 4 SEC Filings 01/20/2017
Rezolute, Inc. (RZLT) - 4 SEC Filings 01/18/2017
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 01/17/2017
Rezolute, Inc. (RZLT) - 4 SEC Filings 01/17/2017
Rezolute, Inc. (RZLT) - S-1/A SEC Filings 01/13/2017
Rezolute, Inc. (RZLT) - 4 SEC Filings 01/13/2017
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 01/05/2017
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 12/29/2016
Rezolute, Inc. (RZLT) - SC TO-I/A SEC Filings 12/27/2016
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 12/22/2016
Rezolute, Inc. (RZLT) - SC TO-I SEC Filings 12/15/2016
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 12/15/2016
Rezolute, Inc. (RZLT) - S-1 SEC Filings 12/08/2016
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 11/14/2016
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 11/07/2016
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 11/04/2016
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 10/25/2016
Rezolute, Inc. (RZLT) - POS AM SEC Filings 10/14/2016
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 10/06/2016
Rezolute, Inc. (RZLT) - 10-K - Current report SEC Filings 09/28/2016
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 09/22/2016
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 07/29/2016
Rezolute, Inc. (RZLT) - D SEC Filings 07/13/2016
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 06/29/2016
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 06/22/2016
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 06/03/2016
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 05/17/2016
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 05/16/2016
Rezolute, Inc. (RZLT) - D/A SEC Filings 03/22/2016
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 03/15/2016
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 03/02/2016
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 02/16/2016
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 02/16/2016
Rezolute, Inc. (RZLT) - 4 SEC Filings 01/11/2016
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 01/06/2016
Rezolute, Inc. (RZLT) - D SEC Filings 12/21/2015
Rezolute, Inc. (RZLT) - 4 SEC Filings 12/21/2015
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 12/17/2015
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 12/10/2015
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 11/17/2015
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 11/16/2015
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 11/16/2015
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 10/27/2015
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 10/23/2015
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 10/23/2015
Rezolute, Inc. (RZLT) - POS AM SEC Filings 10/13/2015
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 09/30/2015
Rezolute, Inc. (RZLT) - 10-K - Current report SEC Filings 09/28/2015
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 09/16/2015
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 08/04/2015
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 07/30/2015
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 07/23/2015
Rezolute, Inc. (RZLT) - S-1/A SEC Filings 07/22/2015
Rezolute, Inc. (RZLT) - S-1/A SEC Filings 07/07/2015
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 07/07/2015
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 06/29/2015
Rezolute, Inc. (RZLT) - 3 SEC Filings 06/29/2015
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 06/08/2015
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 06/03/2015
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 06/01/2015
Rezolute, Inc. (RZLT) - S-1 SEC Filings 05/22/2015
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 05/15/2015
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 05/11/2015
Rezolute, Inc. (RZLT) - D SEC Filings 04/14/2015
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 04/06/2015
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 03/04/2015
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 02/24/2015
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 02/17/2015
Rezolute, Inc. (RZLT) - D SEC Filings 01/26/2015
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 01/08/2015
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 01/07/2015
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 01/05/2015
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 12/04/2014
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 11/26/2014
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 11/12/2014
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 11/10/2014
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 10/24/2014
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 10/24/2014
Rezolute, Inc. (RZLT) - POS AM SEC Filings 09/30/2014
Rezolute, Inc. (RZLT) - NT 10-K - Current report SEC Filings 09/30/2014
Rezolute, Inc. (RZLT) - 10-K - Current report SEC Filings 09/30/2014
Rezolute, Inc. (RZLT) - 3 SEC Filings 09/10/2014
Rezolute, Inc. (RZLT) - SC 13G SEC Filings 09/09/2014
Rezolute, Inc. (RZLT) - 3 SEC Filings 07/25/2014
Rezolute, Inc. (RZLT) - 3 SEC Filings 07/24/2014
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 07/23/2014
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 07/03/2014
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 07/02/2014
Rezolute, Inc. (RZLT) - S-1/A SEC Filings 06/25/2014
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 06/23/2014
Rezolute, Inc. (RZLT) - S-1 SEC Filings 05/20/2014
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 05/14/2014
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 05/12/2014
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 05/06/2014
Rezolute, Inc. (RZLT) - 4 SEC Filings 05/02/2014
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 05/01/2014
Rezolute, Inc. (RZLT) - D/A SEC Filings 04/28/2014
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 04/23/2014
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 04/17/2014
Rezolute, Inc. (RZLT) - D SEC Filings 04/14/2014
Rezolute, Inc. (RZLT) - DEF 14C SEC Filings 04/10/2014
Rezolute, Inc. (RZLT) - 4 SEC Filings 04/10/2014
Rezolute, Inc. (RZLT) - 4 SEC Filings 04/09/2014
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 04/08/2014
Rezolute, Inc. (RZLT) - PRER14C SEC Filings 04/08/2014
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 04/07/2014
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 04/07/2014
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 04/04/2014
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 04/02/2014
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 04/01/2014
Rezolute, Inc. (RZLT) - PRE 14C SEC Filings 03/31/2014
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 02/13/2014
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 02/05/2014
Rezolute, Inc. (RZLT) - SC 13D SEC Filings 01/24/2014
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 01/16/2014
Rezolute, Inc. (RZLT) - D SEC Filings 01/14/2014
Rezolute, Inc. (RZLT) - RW SEC Filings 12/19/2013
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 12/19/2013
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 11/15/2013
Rezolute, Inc. (RZLT) - S-1/A SEC Filings 11/14/2013
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 11/12/2013
Rezolute, Inc. (RZLT) - S-1 SEC Filings 09/30/2013
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 09/30/2013
Rezolute, Inc. (RZLT) - 10-K - Current report SEC Filings 09/11/2013
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 07/24/2013
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 07/01/2013
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 05/15/2013
Rezolute, Inc. (RZLT) - 4 SEC Filings 04/18/2013
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 02/22/2013
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 02/19/2013
Rezolute, Inc. (RZLT) - 8-K/A - Current report SEC Filings 02/14/2013
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 02/14/2013
Rezolute, Inc. (RZLT) - SC 13D SEC Filings 02/11/2013
Rezolute, Inc. (RZLT) - SC 13D SEC Filings 02/08/2013
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 02/08/2013
Rezolute, Inc. (RZLT) - 3 SEC Filings 02/08/2013
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 02/06/2013
Rezolute, Inc. (RZLT) - SC 14F1 SEC Filings 01/14/2013
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 01/11/2013
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 01/07/2013
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 12/19/2012
Rezolute, Inc. (RZLT) - DEF 14C SEC Filings 12/19/2012
Rezolute, Inc. (RZLT) - PRER14C SEC Filings 12/13/2012
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 12/13/2012
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 12/11/2012
Rezolute, Inc. (RZLT) - PRE 14C SEC Filings 12/03/2012
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 11/19/2012
Rezolute, Inc. (RZLT) - NT 10-Q - Quarterly Report SEC Filings 11/14/2012
Rezolute, Inc. (RZLT) - 10-K/A - Current report SEC Filings 11/09/2012
Rezolute, Inc. (RZLT) - 10-K - Current report SEC Filings 11/05/2012
Rezolute, Inc. (RZLT) - SC 13G/A SEC Filings 10/10/2012
Rezolute, Inc. (RZLT) - NT 10-K - Current report SEC Filings 10/01/2012
Rezolute, Inc. (RZLT) - SC 13D/A SEC Filings 09/14/2012
Rezolute, Inc. (RZLT) - 8-K - Current report SEC Filings 09/07/2012
Rezolute, Inc. (RZLT) - 4 SEC Filings 09/06/2012
Rezolute, Inc. (RZLT) - 4 SEC Filings 06/13/2012
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 05/16/2012
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 05/15/2012
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 02/16/2012
Rezolute, Inc. (RZLT) - SC 13G SEC Filings 02/14/2012
Rezolute, Inc. (RZLT) - SC 13D SEC Filings 02/14/2012
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 02/14/2012
Rezolute, Inc. (RZLT) - 10-Q/A - Quarterly Report SEC Filings 12/13/2011
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 11/15/2011
Rezolute, Inc. (RZLT) - 10-Q - Quarterly Report SEC Filings 11/14/2011
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 09/28/2011
Rezolute, Inc. (RZLT) - 10-K - Current report SEC Filings 09/22/2011
Rezolute, Inc. (RZLT) - 3 SEC Filings 09/19/2011
Rezolute, Inc. (RZLT) - 8-A12G SEC Filings 09/09/2011
Rezolute, Inc. (RZLT) - EFFECT SEC Filings 08/15/2011
Rezolute, Inc. (RZLT) - 424B3 SEC Filings 08/15/2011
Rezolute, Inc. (RZLT) - S-1/A SEC Filings 08/11/2011
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 08/11/2011
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 08/10/2011
Rezolute, Inc. (RZLT) - S-1/A SEC Filings 08/08/2011
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 08/05/2011
Rezolute, Inc. (RZLT) - S-1/A SEC Filings 07/20/2011
Rezolute, Inc. (RZLT) - CORRESP SEC Filings 07/20/2011
Rezolute, Inc. (RZLT) - UPLOAD SEC Filings 07/11/2011
Rezolute, Inc. (RZLT) - S-1 SEC Filings 06/14/2011
Rezolute, Inc. (RZLT) - D SEC Filings 05/17/2011

Press Releases

StockPrice Release
Phase 2 rize study sub-analyses to be presented at the 2024 pediatric endocrine society annual meeting 04/23/2024
Rezolute reports validation of the potential use of rz358 for treatment of non-islet cell tumor hypoglycemia (nicth) 03/06/2024
Rezolute reports second quarter fiscal 2024 results and provides business update 02/13/2024
Rezolute expands leadership team with appointment of daron evans, ms, mba, as chief financial officer 01/24/2024
Rezolute receives innovation passport designation from the u.k. innovative licensing and access pathway steering group for rz358 in the treatment of hypoglycemia due to congenital hyperinsulinism 01/23/2024
Rezolute initiates phase 3 clinical study for rz358 in congenital hyperinsulinism 12/14/2023
Rezolute completes enrollment of its phase 2 study in diabetic macular edema (“dme”) 12/13/2023
Stonegate healthcare partners announces black friday biotech special report for an "xbi-mas" 11/24/2023
Rezolute to participate in btig's 3rd annual ophthalmology day 11/17/2023
Rezolute reports first quarter fiscal 2024 results 11/13/2023
Rezolute receives priority medicines (prime) eligibility from european medicines agency for enhanced regulatory support of rz358 in congenital hyperinsulinism 10/17/2023
Rezolute announces further evidence of rz358's efficacy in tumor-mediated hyperinsulinism 10/11/2023
Rezolute reports full year fiscal 2023 results and highlights company progress 09/14/2023
Rezolute to participate in upcoming investor conferences in september 09/06/2023
Rezolute to initiate a pivotal phase 3 study of rz358 in participants 3 months of age and older with congenital hyperinsulinism 06/27/2023
Stonegate healthcare partners announces publishing of a thematic report - beyond vegf: therapies revolutionizing diabetic eye disease 06/01/2023
Rezolute kol event highlights significant unmet medical need in diabetic macular edema 03/23/2023
Rezolute to highlight rz402 phase 2 clinical program with leading clinical expert 03/08/2023
Rezolute reports second quarter fiscal 2023 results and highlights company progress 02/10/2023
Rezolute announces initiation of a phase 2 study of rz402 in patients with diabetic macular edema 12/15/2022
Rezolute reports first quarter fiscal 2023 results and highlights company progress 11/09/2022
Rezolute to present at the jefferies london healthcare conference 11/01/2022
Rezolute announces presentation at the retina society 55th annual scientific meeting 10/20/2022
Rezolute reports fourth quarter and full year fiscal 2022 results and highlights company progress 09/15/2022
Rezolute announces presentation at the 60th annual espe meeting 09/07/2022
Rezolute announces promotion of brian roberts, m.d. to chief medical officer 06/01/2022
Rezolute reports third quarter fiscal 2022 financial results and highlights company progress 05/12/2022
Rezolute, inc. announces closing of registered direct offering 05/04/2022
Rezolute, inc. announces aggregate $130 million registered direct offering and concurrent private placement priced at-the-market 05/01/2022
Rezolute announces positive data from its phase 2b (rize) study of rz358 in patients with congenital hyperinsulinism 05/01/2022
Rz358 phase 2b (rize study) topline data to be unveiled at pediatric endocrine society annual meeting on may 1, 2022 04/26/2022
Rezolute joins the rare disease company coalition 03/29/2022
Rezolute announces positive results from the phase 2b rize study of rz358 in congenital hyperinsulinism 03/23/2022
Rezolute announces positive study results for rz402, an oral pki being developed for dme 02/22/2022
Rezolute reports first quarter fiscal 2022 financial results and highlights recent company progress 11/12/2021
Rezolute announces pricing of public offering of $55 million of common stock and pre-funded warrants, and concurrent registered direct offering 10/13/2021
Rezolute announces proposed public offering of common stock and pre-funded warrants, and a concurrent registered direct offering 10/12/2021
Rezolute presents results from two-week natural history study in congenital hyperinsulinism patients on standard of care therapies at espe 2021 09/22/2021
Rezolute reports fourth quarter and full year fiscal 2021 financial results and highlights recent company progress 09/15/2021
Rezolute announces initiation of dosing in the second cohort of its phase 2b trial of rz358 for congenital hyperinsulinism 09/09/2021
Rezolute to participate in upcoming virtual healthcare conferences 09/07/2021
Rezolute to participate in upcoming virtual healthcare conferences 08/03/2021
Rezolute added to russell microcap® index 06/28/2021
Rezolute expands leadership team with the appointment of davelyn hood, md as director, scientific and patient affairs 05/20/2021
Rezolute to present at the oppenheimer rare and orphan disease summit 05/17/2021
Rezolute to participate in upcoming investor conferences in march 03/02/2021
Rezolute reports second quarter fiscal 2021 financial results 02/10/2021
Rezolute announces initiation of phase 1 study of rz402, an oral plasma kallikrein inhibitor for the treatment of diabetic macular edema 01/12/2021
Rezolute announces change of transfer agent 12/28/2020

More Headlines

News
Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants, and a Concurrent Registered Direct Offering REDWOOD CITY, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases associated with chronic glucose imbalance, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering, and, in lieu of common stock, Rezolute intends to offer and sell to certain investors pre-funded warrants to purchase shares of its common stock. Concurrently with the public offering and by means of a prospectus supplement and accompanying prospectus, Rezolute is offering to sell shares of its common stock directly to certain institutional investors that are current shareholders, in a registered direct offering. 10/12/2021
Rezolute Presents Results from Two-Week Natural History Study in Congenital Hyperinsulinism Patients on Standard of Care Therapies at ESPE 2021 Continuous glucose monitoring reveals undertreated hypoglycemia in patients with congenital hyperinsulinism 09/22/2021
Rezolute Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results and Highlights Recent Company Progress REDWOOD CITY, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases associated with chronic glucose imbalance, today announced its financial results for the fourth quarter and fiscal full year ended June 30, 2021. 09/15/2021
Rezolute Announces Initiation of Dosing in the Second Cohort of its Phase 2b Trial of RZ358 for Congenital Hyperinsulinism Tracking to Announce Top line data in Q1 2022 09/09/2021
Rezolute to Participate in Upcoming Virtual Healthcare Conferences REDWOOD CITY, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases related to chronic glucose imbalance, today announced that Nevan Charles Elam, CEO and Founder, will present at two upcoming virtual investment conferences. 09/07/2021
Rezolute Added to Russell Microcap® Index REDWOOD CITY, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases related to chronic glucose imbalance, has been added to the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28. 06/28/2021
5 Stock Gainers For May 27: VTNR, GOED, RZLT, AMC, RVPH Here is an overview of 5 of the top stock gainers for May 21 and why the stock prices moved. The post 5 Stock Gainers For May 27: VTNR, GOED, RZLT, AMC, RVPH appeared first on Pulse 2.0. 05/27/2021
RZLT Stock Price: Over 85% Increase Explanation The stock price of Rezolute Inc (NASDAQ: RZLT) increased by over 85% during intraday trading. This is why it happened. 05/27/2021
Rezolute Expands Leadership Team with the Appointment of Davelyn Hood, MD as Director, Scientific and Patient Affairs REDWOOD CITY, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases associated with chronic glucose imbalance, today announced the addition of Davelyn Hood, MD, to its leadership team as Director, Scientific and Patient Affairs. In her new role, Dr. Hood will be a key member of the team in furthering the development of RZ358, Rezolute's monoclonal antibody currently being evaluated in a Phase 2b clinical trial to treat congenital hyperinsulinism, a rare disease that is the most common cause of persistent low blood sugars in children. 05/20/2021
Rezolute to Present at the Oppenheimer Rare and Orphan Disease Summit REDWOOD CITY, Calif., May 17, 2021 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company developing novel therapies for diseases caused by chronic glucose imbalance, today announced that management will present at the Oppenheimer Rare and Orphan Disease Summit. The presentation will be available on-demand starting at 8:00 AM ET on Friday, May 21, 2021. 05/17/2021
Rezolute to Participate in Upcoming Investor Conferences in March REDWOOD CITY, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), today announced that Nevan Charles Elam, the Company's CEO and Founder, will be presenting at the following upcoming investor conferences: 03/02/2021
Rezolute Reports Second Quarter Fiscal 2021 Financial Results REDWOOD CITY, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), today announced its financial results for the quarter ended December 31, 2020. 02/10/2021
Rezolute Announces Initiation of Phase 1 Study of RZ402, an Oral Plasma Kallikrein Inhibitor for the Treatment of Diabetic Macular Edema RZ402 is a plasma kallikrein inhibitor being investigated as a potential once-daily, oral therapy for DME 01/12/2021

Unlock

RZLT Ratings Summary

RZLT Quant Ranking